fluoxetine has been researched along with oxazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cleary, EW; Huffman, CS; Polvino, WJ; Smith, DA; Watkins, S | 1 |
| Moser, PC; Sanger, DJ | 1 |
| Cistarelli, L; Gobert, A; Melon, C; Millan, MJ; Rivet, JM | 1 |
| Aparicio, N; Fernández, C; Sánchez-Argüello, P | 1 |
| Gu, QY; Jiang, B; Ni, YF; Wang, FY; Wang, H; Wang, JL; Wang, YJ | 1 |
| Qi, X; Wang, L; Xu, H; Zhang, Z | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
1 trial(s) available for fluoxetine and oxazoles
| Article | Year |
|---|---|
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers.
Topics: Adolescent; Adult; Cranial Sinuses; Cross-Over Studies; Dizziness; Drug Interactions; Drug Tolerance; Female; Fluoxetine; Humans; Intracranial Pressure; Male; Middle Aged; Nausea; Oxazoles; Oxazolidinones; Patient Compliance; Pharyngitis; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptamines | 1998 |
6 other study(ies) available for fluoxetine and oxazoles
| Article | Year |
|---|---|
5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Drug Interactions; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Oxazoles; Pindolol; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Swimming | 1999 |
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Buspirone; Chromatography, High Pressure Liquid; Dopamine; Dopamine Antagonists; Drug Interactions; Fluoxetine; Frontal Lobe; Locomotion; Male; Microdialysis; Neural Inhibition; Norepinephrine; Oxazoles; Piperazines; Pyridines; Raclopride; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |
Linking embryo toxicity with genotoxic responses in the freshwater snail Physa acuta: single exposure to benzo(a)pyrene, fluoxetine, bisphenol A, vinclozolin and exposure to binary mixtures with benzo(a)pyrene.
Topics: Animals; Benzhydryl Compounds; Benzo(a)pyrene; DNA Damage; Embryo, Nonmammalian; Fluoxetine; Fresh Water; Micronucleus Tests; Mutagens; Oxazoles; Phenols; Snails; Toxicity Tests; Water Pollutants, Chemical | 2012 |
Gemfibrozil has antidepressant effects in mice: Involvement of the hippocampal brain-derived neurotrophic factor system.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Carbazoles; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Gemfibrozil; Hippocampus; Immobility Response, Tonic; Indole Alkaloids; Male; Membrane Glycoproteins; Mice; Motor Activity; Oxazoles; Protein-Tyrosine Kinases; RNA, Small Interfering; Serotonin; Signal Transduction; Tyrosine | 2018 |
Comparison of Therapeutic Effects of TREK1 Blockers and Fluoxetine on Chronic Unpredicted Mild Stress Sensitive Rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Behavior, Animal; Bridged Bicyclo Compounds; Cell Proliferation; Dentate Gyrus; Depression; Disease Models, Animal; Fluoxetine; Neurogenesis; Oxazoles; Peptides; Potassium Channels, Tandem Pore Domain; Rats; Stress, Psychological | 2018 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |